Combination of Low-dose Nalbuphine and Morphine in Patient-controlled Analgesia Decreases Incidence of Opioid-related Side Effects

The addition of ultra-low-dose naloxone to patient-controlled analgesia (PCA) with morphine reduces opioid-related side effects. Nalbuphine, a mixed opioid agonist–antagonist, may be able to attenuate opioid-related side effects. The goal of the present study was to investigate the effect of combine...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yu-Chang Yeh, Tzu-Fu Lin, Hung-Chi Chang, Wing-Sum Chan, Yong-Ping Wang, Chen-Jung Lin, Wei-Zen Sun
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2009-07-01
Edice:	Journal of the Formosan Medical Association
Témata:	adverse effects morphine nalbuphine opioids patient-controlled analgesia
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S0929664609603727
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!